Cumberland Pharmaceuticals Inc (CPIX)

Currency in USD
7.320
+0.130(+1.81%)
Closed·
7.604+0.284(+3.87%)
·
Advertisement
High dividend Yield
CPIX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.0207.340
52 wk Range
1.8509.280
Key Statistics
Prev. Close
7.32
Open
7.19
Day's Range
7.02-7.34
52 wk Range
1.85-9.28
Volume
27.65K
Average Volume (3m)
91.54K
1-Year Change
132.381%
Book Value / Share
1.16
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CPIX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Pays a significant dividend to shareholders
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Cumberland Pharmaceuticals Inc Earnings Call Summary for Q2/2026

  • Cumberland completed sale of commercial brands to Apotex for $100M upfront, $11M deferred, pivoting to development-stage biopharmaceutical company.
  • Q2 2026 operating loss of $3.1M, net loss of $4.1M; paid $22M special dividend ($1.50/share) and retired $5.2M credit line with proceeds.
  • Company projects cash runway exceeding five years with $50M+ in reserves; shares rose 8.22% to $7.77, then fell 8.11% after-hours to $7.14.
  • Ifetroban pipeline advancing: DMD FDA meeting expected fall 2026, systemic sclerosis and IPF interim results due 2026, oncology under evaluation.
  • Management emphasizes strategic shift from commercial to innovation-focused model; 99% shareholder approval reflects confidence in clinical execution strategy.
Last Updated: 04/08/2026, 22:34
Read Full Transcript

Earnings

Latest Release
04/08/2026
EPS / Forecast
-0.20 / --
Revenue / Forecast
166.45M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.22%
Dividend Yield
20.49%
Industry Median 2.31%
Annualised payout
1.50
Paid unevenly
5-Years Growth
-
Growth Streak

Compare CPIX to Peers and Sector

Metrics to compare
CPIX
Peers
Sector
Relationship
P/E Ratio
−34.3x−3.3x−0.4x
PEG Ratio
0.13−0.040.00
Price/Book
6.3x1.1x2.6x
Price / LTM Sales
2.5x1.6x3.0x
Upside (Analyst Target)
-173.5%54.5%
Fair Value Upside
Unlock4.4%7.2%Unlock

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; and Tacilia, an oral capsule for the treatment of H. pylori infection. It also develops ifetroban, a product candidate that has completed Phase II clinical trials for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy, hepatorenal syndrome, portal hypertension, aspirin-exacerbated respiratory disease, systemic sclerosis, and idiopathic pulmonary fibrosis. It serves hospital acute care, gastroenterology, and oncology markets in the United States, China, South Korea, Russia, Mexico, Australia, and Saudi Arabia. The company has a strategic alliance agreement with WinHealth Pharma Group Co. Limited. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Employees
88

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
846.43K5.65%6.20M
Other Institutional Investors
2.27M15.14%16.61M
Public Companies & Retail Investors
11.87M79.21%86.87M
Total
14.98M100.00%109.68M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Integrated Core Strategies (US) LLC4.00%598,6344,382
Ikarian Capital, LLC3.36%503,1533,683

People Also Watch

0.966
NAUT
-0.62%
2.95
SITC
+0.68%
4.470
OABI
+0.68%
30.27
ANRO
-2.29%

FAQ

What Is the Cumberland (NASDAQ: CPIX) Share Price Today?

The Cumberland stock price today is 7.320 USD.

What Stock Exchange Does Cumberland (CPIX) Trade On?

Cumberland is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Cumberland?

The stock symbol (also called a 'ticker') for Cumberland is "CPIX."

Does Cumberland Pay Dividends? What’s The Current CPIX Dividend Yield?

Yes, CPIX Pays Dividends to its Shareholders. The current Cumberland dividend yield is 20.49%.

What Is the Current Cumberland Market Capitalisation?

As of today, Cumberland (NASDAQ: CPIX) market cap is 109.680M USD.

What Is Cumberland's (CPIX) Earnings Per Share (TTM)?

The Cumberland EPS is currently -0.221 (Trailing Twelve Months).

When Is the Next Cumberland Earnings Date?

Cumberland's next earnings report will be released on 10/11/2026.

Is CPIX a Buy or Sell From a Technical Analyst Perspective?

Based on today's Cumberland moving averages and other technical indicators, the daily buy/sell signal for CPIX stock is Strong Buy.

How Many Times Has Cumberland Stock Split?

Cumberland has split 0 times. (See the CPIX stock split history page for full effective split date and price information.)

How Many Employees Does Cumberland Have?

Cumberland has 88 employees, based on their latest Companies House report.

What is the current trading status of Cumberland (NASDAQ: CPIX)?

As of 20/09/2026, Cumberland (CPIX) is trading at a share price of 7.320 USD, with a previous close of 7.320 USD. The stock has fluctuated within a day range of 7.020 USD to 7.340 USD, while its 52-week range spans from 1.850 USD to 9.280 USD.

What Is the CPIX After Hours Price?

CPIX's last after hours stock price is 7.604 USD, the stock has decreased by 0.284, or 3.870%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.